ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1329

Prevalence of Bone Fragility on DXA and CT in Patients with Obesity

Marion Halin1, Edem Allado1, Didier Quilliot1, Eliane Albuisson1, Isabelle Chary-Valckenaere1, Damien Loeuille1, Laurent Brunaud1 and Marine FAUNY2, 1Nancy University Hospital, Vandoeuvre, France, 2Nancy University Hospital, Toul, France

Meeting: ACR Convergence 2022

Keywords: Bone density, Dual energy x-ray absorptiometry (DEXA), Imaging, obesity, osteoporosis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Session Title: Osteoporosis and Metabolic Bone Disease – Basic and Clinical Science Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Primary objective was to evaluate bone fragility prevalence on dual X-ray absorptiometry (DXA) and on computed tomography (CT), in patients with severe obesity. Secondary objective was to evaluate the risk factors for bone fragility.

Methods: This monocentric study was conducted in patients with grade 2 and 3 obesity, who performed a CT and/or a DXA within two years. Bone mineral density (BMD) and T-score were studied on DXA and scanographic bone attenuation coefficient of L1 (SBAC-L1) was measured on CT. Bone fragility was defined by T-score≤-2.5 standard deviation (SD) and an SBAC-L1≤145 Hounsfield units (HU). The diagnosis of osteoporosis was retained for a T-score ≤ − 2.5 SD and osteopenia for -2.5 SD < T-score ≤ -1 SD.

Results: Among 1386 patients included, 1013 had performed both DXA and CT within less than 2 years. Mean age was 48.4 years (±11.4), 77.6% were women and mean BMI was 45.6 kg/m² (±6.7). Eight patients (0.8%) had osteoporosis on at least one site and 119 (11.7%) had osteopenia. Mean SBAC-L1 was 192.3 HU (±52.4); 163 patients (16.1%) were under the fracture threshold of 145HU. Older age (OR[CI95]=1.1 [1.08-1.16]), lower BMD on femoral neck and spine (OR[CI95]=0.04[0.005-0.33] and OR[CI95]=0.001[0.0001-0.008], respectively), and higher lean mass (OR[CI95]=1.1[1.03-1.13]) were significantly associated with an SBAC-L1≤145HU in multivariate analysis. BMI was a protective factor (OR[CI95]=0.9[0.82-0.92].

Conclusion: About 16% of patients with grade 2 and 3 obesity were under the SBAC-L1 fracture threshold, when less than 1% were classified as osteoporotic on DXA. Risk factors for an SBAC-L1≤145HU were older age, lower BMI, lower BMD on femoral neck or spine and higher lean mass.


Disclosures: M. Halin, None; E. Allado, None; D. Quilliot, None; E. Albuisson, None; I. Chary-Valckenaere, None; D. Loeuille, None; L. Brunaud, None; M. FAUNY, None.

To cite this abstract in AMA style:

Halin M, Allado E, Quilliot D, Albuisson E, Chary-Valckenaere I, Loeuille D, Brunaud L, FAUNY M. Prevalence of Bone Fragility on DXA and CT in Patients with Obesity [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/prevalence-of-bone-fragility-on-dxa-and-ct-in-patients-with-obesity/. Accessed March 28, 2023.
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-bone-fragility-on-dxa-and-ct-in-patients-with-obesity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences